Skip links

Kalbitor® (ecallantide)

Full Name Kalbitor® (ecallantide)
Drug Kalbitor
Manufacturer Takeda Pharmaceuticals U.S.A., Inc.
Route of Administration Subcutaneous
Site of Care Home
Approved Indication Treatment of acute attacks of hereditary angioedema (HAE) in patients 12 years of age and older
Disease Hereditary Angioedema (HAE)
Therapeutic Area Allergy & Immunology
Enrollment Form Link Enrollment Form
Phone Number 800-356-4252
Fax Number 847-631-6918
Product Website